Telinod 40/5 ; 40/10 ; 80/5 ; 80/10 40/5 mg; 40/10 mg; 80/5 mg ; 80/10 mg tablets
PDF Leaflet Revision Date: 24 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of essential hypertension.
Dosage (summary)
Adults: 40/5 mg once daily, may titrate to 80/10 mg if needed.
Onset of Action / Duration
Onset: 3 hours, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity
- Severe renal impairment
- Bilateral renal artery stenosis
- Severe hepatic impairment
- Pregnancy and lactation
Common side effects
- Dizziness
- Peripheral oedema
- Hypotension
Counselling Points
- Take once daily, with or without food.
- Monitor blood pressure regularly.
- Avoid potassium supplements.
Serious warnings
- Risk of hypotension with dual RAAS blockade
- Monitor renal function in renal impairment
Important Disclaimer
The Telinod 40/5 ; 40/10 ; 80/5 ; 80/10 40/5 mg; 40/10 mg; 80/5 mg ; 80/10 mg tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
